<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>23</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>04</Month>
        <Day>07</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Prevalence and Severity of COVID-19 among Pediatric Patients with Atopy:  A Cross-sectional Study in Kerman, Southeast Iran</title>
    <FirstPage>127</FirstPage>
    <LastPage>138</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Fakhry</FirstName>
        <LastName>Shafiee</LastName>
        <affiliation locale="en_US">Afzalipour Research Development Unit, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Afshin</FirstName>
        <LastName>Sarafinejad</LastName>
        <affiliation locale="en_US">Clinical Informatics Research and Development Lab, Clinical Research Development Unit, Shafa Hospital,  Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nasrin</FirstName>
        <LastName>Bazargan Harandi</LastName>
        <affiliation locale="en_US">Department of Pediatrics, School of Medicine Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Hossininasab</LastName>
        <affiliation locale="en_US">Department of Pediatrics, School of Medicine Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sareh Saadat</FirstName>
        <LastName>Ebrahimi</LastName>
        <affiliation locale="en_US">Department of Pediatrics, School of Medicine Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>08</Month>
        <Day>03</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>12</Month>
        <Day>03</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The tragic COVID-19 pandemic affected many children worldwide. Among the factors that may influence the course of viral infections including COVID-19, it is still uncertain whether atopy has a protective or predisposing role. The study aims to address the knowledge gap by investigating the prevalence and severity of COVID-19 among atopic children in Kerman, in 2022.
A descriptive-analytical cross-sectional study on children with a history of atopy was performed in Kerman Medical University. Demographic information, type of atopy (including allergic rhinitis, Hyper-Reactive Airway Disease (HRAD) or asthma, eczema, urticaria, anaphylaxis, and food allergy), history of COVID-19 infection, and disease severity were recorded.
A total of 1007 children and adolescents, (boys: 56.4%, girls: 43.6%, age:5.61&#xB1;2.64 years) were included in the study. History of COVID-19 infection was positive in 53.5%, with 75.9% of the cases exhibiting mild disease severity. The frequency of atopies was HRAD or asthma (67.2%), allergic rhinitis (42.6%), and food allergy (27.4%). The frequency of COVID-19 cases was significantly higher among patients with HRAD or asthma, whereas it was significantly lower among those with food allergies, anaphylaxis, and eczema. Among atopic individuals, COVID-19 severity was significantly lower in those with allergic rhinitis, while the opposite trend was observed among food-allergic individuals.
This study sheds light on the relationship between atopy and COVID-19 among pediatric patients. It seems specific types of atopies may influence the risk and severity of COVID-19 infection differently. A better understanding of these associations can inform clinical management and preventive measures for vulnerable pediatric populations.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/3861</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/3861/2024</pdf_url>
  </Article>
</Articles>
